Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


A major upgrade for independent medical research in NZ

A major upgrade for independent medical research in New Zealand

Wellington’s Malaghan Institute of Medical Research has announced a $28 million boost for cancer, asthma and inflammatory disease research in New Zealand.

Cancer and asthma are some of New Zealand’s most devastating diseases. The Malaghan Institute has been recognised as a key independent organisation to meet this challenge through the recent granting of $28 million by the Health Research Council of New Zealand (HRC). The funding, which will be provided over the next seven years, secures a solid future for the improvement in health for all New Zealanders.

The Malaghan Institute’s Director Professor Graham Le Gros says: “We are humbled by the responsibility and trust placed with us. People of all ages in New Zealand are suffering and we need to find better, cheaper more effective ways to treat them.

“This HRC funding establishes the Malaghan Institute as New Zealands premier independent medical research centre for not only finding better treatments for diseases like cancer and asthma, but also many others that have an immunological, infectious or inflammatory basis. This investment by the Government’s HRC will secure the capability we have developed for the benefit of New Zealand while still allowing us to retain the independent spirit and culture and the philanthropic support that has been the source of our discoveries”

The HRC extensively reviewed the core research programmes headed by Professor’s Franca Ronchese, Ian Hermans, Graham Le Gros and Mike Berridge and gave them the stamp of approval as the most likely to produce breakthrough results in the future.

“This funding gives us the wherewithal to translate the many recent exciting discoveries into practical solutions for patients. The new funding also becomes the platform for our up and coming investigators like Dr Elizabeth Forbes-Blom and Dr Robert Weinkov whose youth and vigour will push us to think more boldly.”

Professor Le Gros says: “When combined with philanthropic support from the community, the Malaghan Institute now has the capability to become one of New Zealands enduring and productive assets for a better future.

"It's really exciting. Our understanding of how to use our immune system to treat diseases like cancer has been transformed over the last few years and this funding will place us at the heart of future advances in other disease areas. We will be able to support and build new collaborations throughout New Zealand and across the world to ensure we produce the cutting edge research discoveries New Zealanders need."

The Institute has been operating for over 40 years in Wellington and brings together over 70 medical researchers from across a wide range of fields, including immunologists, cell biologists and bioinformatic specialists. It is New Zealand’s largest and oldest independent biomedical research organisation.

“As an independent organisation the Malaghan Institute relies on continuing philanthropic support to carry out its work. This new funding provides a secure platform for all our donors and supporters ensuring that their generous gifts are now underpinned by credible capability through the HRC grants.”

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

GDP: NZ Economy Grows Faster-Than-Forecast 0.7%

New Zealand's economy grew at a faster pace than expected in the first quarter of 2016 as construction expanded at the quickest rate in two years. The kiwi dollar jumped after the data was released. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news